About Amie J Goodin
Dr. Goodin is an Assistant Professor within the Department of Pharmaceutical Outcomes and Policy (POP) and the Center for Drug Evaluation and Safety (CoDES). She received her Master of Public Policy degree from the University of Kentucky (UK). She completed her Doctor of Philosophy degree at UK’s Martin School of Public Policy, with specialization in pharmaceutical outcomes and an additional Certificate in Informatics. She completed a Postdoctoral Fellowship at University of Florida POP, specializing in pharmacoepidemiology methods while continuing her work in Health Services Research. She is the lead for Health Services Research track within POP’s graduate program as well as the faculty lead for Research Strategy within the Consortium for Medical Marijuana Clinical Outcomes Research. Currently, her research projects incorporate mixed-method approaches to assess the impact of policy changes related to treatment access and utilization for Substance Use Disorders, particularly among persons enrolled in Medicaid and pregnant women.
- Health Policy
- Health disparities and vulnerable populations
- Maternal and Child Health
- Substance Use Disorders
- health services research
UF researchers found the number of new opioid users per month dropped 16 percent immediately after Florida House Bill 21 was implemented.
The UF measure tracks 30-day hospital readmission rates for psychiatric patients following discharge.
“Current policies to limit opioid prescriptions leave some pain patients high and dry, resulting in a new wave of unintended consequences for patients with untreated chronic pain.”
Assistant Scientist Amie Goodin, Ph.D., publishes an editorial in the American Journal of Public Health on the opioid epidemic.